Early research (Phase 1)Study completedNCT00006022
What this trial is testing
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
Who this might be right for
Kidney CancerMelanoma (Skin)
Virginia Commonwealth University 17